Published November 2017 | Version v1
Journal article

Visualization of HER2-specific breast cancer intratumoral heterogeneity using 64Cu-DOTA-trastuzumab PET

  • 1. Hiroshima University, Surgical Oncology, Research Institute for Radiation Biology and Medicine, Hiroshima (Japan)
  • 2. National Cancer Center Hospital, Department of Breast and Medical Oncology, Tokyo (Japan)
  • 3. National Cancer Center Hospital, Department of Diagnostic Radiology, Tokyo (Japan)
  • 4. National Cancer Center Hospital, Department of Breast Surgery, Tokyo (Japan)
  • 5. National Cancer Center Hospital, Department of Pathology and Clinical Laboratories, Tokyo (Japan)
  • 6. National Cancer Center Research Institute, Division of Molecular Pharmacology and Pharmacokinetics, Tokyo (Japan)
  • 7. RIKEN Center for Life Science Technologies, Hyogo (Japan)

Description

no abstract available

Availability note (English)

Available from: http://dx.doi.org/10.1007/s00259-017-3781-6

Additional details

Identifiers

Publishing Information

Journal Title
European Journal of Nuclear Medicine and Molecular Imaging
Journal Volume
44
Journal Issue
12
Journal Page Range
p. 2146-2147
ISSN
1619-7070
CODEN
EJNMA6